Lippoldt Darin bought NBIX
June 29, 2026 · Form 4 insider transaction
Lippoldt Darin bought 1,690 shares of Neurocrine Biosciences, Inc. at $81.49 per share, a transaction worth $137.7K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
1,690
Price
$81.49
Total value
$137.7K
InsiderLippoldt Darin
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJune 29, 2026
Filing dateJune 30, 2026
Shares owned after56,419
OwnershipDirect
10b5-1 planNo
AmendedNo